MLSS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MLSS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Warning Sign:
Piotroski F-Score of 3 is low, which usually implies poor business operation.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Milestone Scientific has an F-score of 3. It is a bad or low score, which usually implies poor business operation.
The historical rank and industry rank for Milestone Scientific's Piotroski F-Score or its related term are showing as below:
During the past 13 years, the highest Piotroski F-Score of Milestone Scientific was 5. The lowest was 2. And the median was 3.
The historical data trend for Milestone Scientific's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Milestone Scientific Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Piotroski F-Score | Get a 7-Day Free Trial | 5.00 | 3.00 | 4.00 | 2.00 | 3.00 |
Milestone Scientific Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Piotroski F-Score | Get a 7-Day Free Trial | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 |
For the Medical Instruments & Supplies subindustry, Milestone Scientific's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Milestone Scientific's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Milestone Scientific's Piotroski F-Score falls into.
How is the Piotroski F-Score calculated?
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Dec23) TTM: | Last Year (Dec22) TTM: |
Net Income was -1.308 + -2.216 + -1.466 + -1.939 = $-6.93 Mil. Cash Flow from Operations was -2.004 + -1.024 + -1.053 + -1.246 = $-5.33 Mil. Revenue was 2.598 + 2.91 + 2.059 + 2.261 = $9.83 Mil. Gross Profit was 1.889 + 1.89 + 1.503 + 1.51 = $6.79 Mil. Average Total Assets from the begining of this year (Dec22) to the end of this year (Dec23) was (13.702 + 12.273 + 11.151 + 10.584 + 11.372) / 5 = $11.8164 Mil. Total Assets at the begining of this year (Dec22) was $13.70 Mil. Long-Term Debt & Capital Lease Obligation was $0.28 Mil. Total Current Assets was $10.79 Mil. Total Current Liabilities was $3.08 Mil. |
Net Income was -1.902 + -2.858 + -1.972 + -1.974 = $-8.71 Mil. Revenue was 2.701 + 1.648 + 2.216 + 2.241 = $8.81 Mil. Gross Profit was 1.682 + 0.681 + 1.453 + 1.085 = $4.90 Mil. Average Total Assets from the begining of last year (Dec21) to the end of last year (Dec22) was (19.81 + 19.065 + 16.512 + 15.278 + 13.702) / 5 = $16.8734 Mil. Total Assets at the begining of last year (Dec21) was $19.81 Mil. Long-Term Debt & Capital Lease Obligation was $0.40 Mil. Total Current Assets was $12.97 Mil. Total Current Liabilities was $3.30 Mil. |
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Milestone Scientific's current Net Income (TTM) was -6.93.
==> Negative ==> Score 0.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Milestone Scientific's current Cash Flow from Operations (TTM) was -5.33.
==> Negative ==> Score 0.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
Score 1 if it's higher, 0 if it's lower.
ROA (This Year) | = | Net Income | / | Total Assets (Dec22) |
= | -6.929 | / | 13.702 | |
= | -0.5056926 |
ROA (Last Year) | = | Net Income | / | Total Assets (Dec21) |
= | -8.706 | / | 19.81 | |
= | -0.43947501 |
Milestone Scientific's return on assets of this year was -0.5056926. Milestone Scientific's return on assets of last year was -0.43947501.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Score 1 if CFROA > ROA, 0 if CFROA <= ROA.
Milestone Scientific's current Net Income (TTM) was -6.93. Milestone Scientific's current Cash Flow from Operations (TTM) was -5.33.
==> -5.33 > -6.93 ==> CFROA > ROA ==> Score 1.
Funding
Question 5. Change in Gearing or Leverage
Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.
Score 0 if this year's gearing is higher, 1 otherwise.
Gearing (This Year: Dec23) | = | Long-Term Debt & Capital Lease Obligation | / | Average Total Assets from Dec22 to Dec23 |
= | 0.282 | / | 11.8164 | |
= | 0.02386514 |
Gearing (Last Year: Dec22) | = | Long-Term Debt & Capital Lease Obligation | / | Average Total Assets from Dec21 to Dec22 |
= | 0.396 | / | 16.8734 | |
= | 0.02346889 |
Milestone Scientific's gearing of this year was 0.02386514. Milestone Scientific's gearing of last year was 0.02346889.
==> Last year is lower than this year ==> Score 0.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Current Ratio (This Year: Dec23) | = | Total Current Assets | / | Total Current Liabilities |
= | 10.794 | / | 3.077 | |
= | 3.5079623 |
Current Ratio (Last Year: Dec22) | = | Total Current Assets | / | Total Current Liabilities |
= | 12.971 | / | 3.3 | |
= | 3.93060606 |
Milestone Scientific's current ratio of this year was 3.5079623. Milestone Scientific's current ratio of last year was 3.93060606.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Milestone Scientific's number of shares in issue this year was 73.979. Milestone Scientific's number of shares in issue last year was 70.987.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Gross Margin (This Year: TTM) | = | Gross Profit | / | Revenue |
= | 6.792 | / | 9.828 | |
= | 0.69108669 |
Gross Margin (Last Year: TTM) | = | Gross Profit | / | Revenue |
= | 4.901 | / | 8.806 | |
= | 0.55655235 |
Milestone Scientific's gross margin of this year was 0.69108669. Milestone Scientific's gross margin of last year was 0.55655235.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Asset Turnover (This Year) | = | Revenue | / | Total Assets at the Beginning of This Year (Dec22) |
= | 9.828 | / | 13.702 | |
= | 0.71726755 |
Asset Turnover (Last Year) | = | Revenue | / | Total Assets at the Beginning of Last Year (Dec21) |
= | 8.806 | / | 19.81 | |
= | 0.44452297 |
Milestone Scientific's asset turnover of this year was 0.71726755. Milestone Scientific's asset turnover of last year was 0.44452297.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score | = | Que. 1 | + | Que. 2 | + | Que. 3 | + | Que. 4 | + | Que. 5 | + | Que. 6 | + | Que. 7 | + | Que. 8 | + | Que. 9 |
= | 0 | + | 0 | + | 0 | + | 1 | + | 0 | + | 0 | + | 0 | + | 1 | + | 1 | |
= | 3 |
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Milestone Scientific has an F-score of 3. It is a bad or low score, which usually implies poor business operation.
Milestone Scientific (AMEX:MLSS) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Thank you for viewing the detailed overview of Milestone Scientific's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.
Peter J Milligan | officer: President | 1650 TYSONS BOULEVARD, SUITE 1700, MCLEAN VA 22102 |
Neal I Goldman | director | 170 SOUTHPORT DRIVE, MORRISVILLE NC 27560 |
Leslie Bernhard | director | C/O ADSTAR, INC., 488 S. ROYAL LANE, COPPELL TX 75019 |
Benedetta I Casamento | director | 200 CAMPUS DRIVE, FLORHAM PARK NJ 07932 |
Leonard Osser | director, 10 percent owner, officer: CEO | |
Leonard M Schiller | director | |
Scott L. Kahn | officer: Chief Financial Officer | 425 EAGLE ROCK AVENUE, SUITE 403, ROSELAND NJ 07068 |
Giandomenico Trombetta | director, 10 percent owner | CORSO VENEZIA 44, MILAN L6 20121 |
Joseph D'agostino | officer: CFO & COO | C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039 |
Jan Adriaan Haverhals | officer: President | 110 WHITE ROCK ROAD, APT. 3304, VERONA NJ 07044 |
Brent W Johnston | officer: President | C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE SUITE 102, LIVINGSTON NJ 07039 |
Michael Mcgeehan | director | C/O MILESTONE SCIENTIFIC INC, LIVINGSTON NJ 07039 |
Edward J. Zelnick | director | C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039 |
Daniel S Goldberger | officer: President and CEO | 24 CARPENTER ROAD, CHESTER NY 10918 |
Bp4 S.r.l. | director, 10 percent owner, officer: See Remarks | CORSO VENEZIA 44, MILAN L6 20121 |
From GuruFocus
By ACCESSWIRE ACCESSWIRE • 06-30-2020
By [email protected] [email protected] • 04-15-2020
By ACCESSWIRE ACCESSWIRE • 06-29-2020
By [email protected] [email protected] • 06-03-2020
By ACCESSWIRE ACCESSWIRE • 08-13-2020
By [email protected] [email protected] • 01-28-2020
By [email protected] [email protected] • 03-30-2020
By PRNewswire PRNewswire • 01-05-2021
By [email protected] [email protected] • 05-29-2020
By ACCESSWIRE ACCESSWIRE • 08-27-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.